Document is current

Article History

Received: 14 April 2023

Accepted: 6 July 2023

First Online: 6 October 2023

Declarations

:

: The study was reviewed and approved by East Midlands—Leicester South Research Ethics Committee (20/EM/0216) on 29 October 2020. It was granted a Clinical Trial Authorisation by the Medicines and Healthcare Products Regulatory Agency on 16 November 2020. Written, informed consent to participate will be obtained from all participants.

: Please see the informed consent forms and information in the supplementary material.

: RU reports grant funding from Medical Research Council (MR/S037675/1) and National Institute of Mental Health (1U01MH124631-01) and speaker fees from Sunovion, Springer Healthcare, and Vitaris outside the submitted work. RU holds an unpaid officership with the British Association for Pharmacology-Honorary General Secretary 2021–2024 and is a deputy editor, The British Journal of Psychiatry.DG reports grant funding from NIHRRP-PG-0615–20009; 202670, and 201707 outside the submitted work.TREB has been a member of an advisory board for Gedeon Richter<i>.</i>NH is a past Trustee of Manchester Global Foundation (MGF), The Pakistan Institute of Living and Learning (PILL), Abaseen Foundation UK, and Lancashire Mind UK. He is an executive member of the Academic Faculty at the Royal College of Psychiatrists. He is a NIHR senior investigator. In the last 5 years, he has attended educational events organised by various pharmaceutical industries.MZHK reports funding from British Medical Association Foundation for Research and Wellcome Trust outside the submitted work.HA holds a Wellcome Trust Investigator Award (219876/Z/19/Z) and reports consultancy fees for advice on economic evaluation methods from Curta, Ferring, PHMR, and Roche outside the submitted work.